While the group again reported a loss for fiscal year 2022, which ended June 30, operating revenue was slightly up at $156.1 million while operating expenses dipped. Overall, Kuakini reported an operating loss of $10.45 million compared with the previous year’s loss of $22.2 million.
When investment and other non-operating income was factored in, the group reported a net loss of $8.7 million compared with $15 million in 2021.
Kuakini was downgraded by S&P in 2021 from “B-” to “CCC” because of “rapid earnings and cash deterioration,” which decreased its cash on hand to 23 days.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
